论文部分内容阅读
目的:探讨复方黄柏液治疗口咽部重型口疮的临床效果。方法:120例口咽部重型口疮患者随机分为对照组和实验组1和实验组2各40例。对照组采用地塞米松5 mg雾化吸入;实验组1采用复方黄柏液10 mL、地塞米松5mg雾化吸入;实验组2采用复方黄柏液10 mL、地塞米松3 mg雾化吸入。结果:实验组1、实验组2的疗效优于对照组,差异具有统计学意义(P<0.05)。实验组1的疗效与实验组2比较,差异不具有统计学意义(P>0.05),三组患者止痛起效时间无差异,实验组1、实验组2镇痛维持时间优于对照组。结论:复方黄柏液雾化吸入治疗口咽部的重型口疮具有良好的临床疗效,并可减少激素的应用量。
Objective: To investigate the clinical efficacy of compound Huangbai liquid in the treatment of oropharyngeal heavy aphthous ulcer. Methods: 120 cases of oropharyngeal severe oral ulcer patients were randomly divided into control group and experimental group 1 and experimental group 2 each 40 cases. The control group was inhaled with 5 mg dexamethasone; experimental group 1 was treated with Compound Cortex Phellodendri 10 mL and dexamethasone 5 mg by atomization; experimental group 2 was treated with Compound Cortex Phellodendri 10 mL and dexamethasone 3 mg. Results: The efficacy of experimental group 1 and experimental group 2 was better than that of the control group (P <0.05). The curative effect of experimental group 1 was not statistically significant compared with experimental group 2 (P> 0.05). There was no difference between the three groups in the onset of analgesia. The maintenance time of experimental group 1 and experimental group 2 was superior to the control group. Conclusion: The compound cortex phellodendri fluid inhalation treatment of oropharyngeal heavy aphthas has a good clinical efficacy, and reduce the amount of hormones.